Arrive AI (NASDAQ:ARAI – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.09) earnings per share (EPS) for the quarter, Zacks reports. Arrive AI had a negative net margin of 13,348.06% and a negative return on equity of 0.95%.
Here are the key takeaways from Arrive AI’s conference call:
- Commercial pipeline is expanding across healthcare, manufacturing, specialty pharmacy, and autonomous delivery. The company cited later-stage discussions, Hancock Regional Hospital’s additional deployment, and partnerships with Nexus AMR and DXC, though only signed agreements will be treated as firm.
- Arrive AI expects more than a dozen AP3 Plus units to be in stock and ready to ship by mid-September, while AP4 is targeted for the first quarter of 2027. Management said the AP4 supply chain is designed to support hundreds of units during 2027, with later generations intended to scale further.
- Financial results remain very small relative to the company’s spending needs. Second-quarter revenue was $14,700, while net loss was $14.1 million, or $4.3 million excluding $9.7 million of non-cash note-conversion expenses; cash and liquid investments totaled $5.1 million against an approximately $1.1 million monthly burn rate.
- Management emphasized that additional financing will be needed or may be pursued, citing a $100 million S-3 registration, a potential $15 million ATM offering, and $19 million of remaining equity-line capacity. Executives said the company is not at immediate risk of running out of funds, but these financing options could result in dilution and reflect ongoing liquidity pressure.
- The company highlighted a growing intellectual-property portfolio, including 10 issued U.S. patents, 13 international patents—primarily in Asia—and a recently approved European patent. Arrive AI plans to explore licensing opportunities in Asia and Europe, although the commercial value of these efforts has not yet been demonstrated.
Arrive AI Price Performance
Shares of ARAI traded down $0.02 during midday trading on Thursday, hitting $0.24. 1,000,041 shares of the company traded hands, compared to its average volume of 4,495,691. The stock has a 50-day moving average of $0.38 and a 200-day moving average of $0.79. Arrive AI has a one year low of $0.22 and a one year high of $6.86. The firm has a market cap of $12.55 million, a P/E ratio of -0.47 and a beta of 4.31.
Hedge Funds Weigh In On Arrive AI
Analyst Ratings Changes
ARAI has been the subject of several analyst reports. Wall Street Zen downgraded shares of Arrive AI from a “hold” rating to a “sell” rating in a report on Saturday, May 16th. Weiss Ratings reissued a “sell (e+)” rating on shares of Arrive AI in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $12.00.
Get Our Latest Stock Analysis on Arrive AI
Arrive AI Company Profile
We were incorporated on April 30, 2020, in the State of Delaware under the name of Dronedek Corporation. The Company changed its name to Arrive Technology Inc on July 27, 2023. The Company changed its name to Arrive AI Inc on September 30, 2024. We are a developmental technology company with a focus on designing and implementing a commercially viable smart mailbox and platform system for smart, secure, and seamless exchange of packages, goods, supplies, food, and medications between people, through the use of robots, and drones.
Read More
- Five stocks we like better than Arrive AI
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Arrive AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrive AI and related companies with MarketBeat.com's FREE daily email newsletter.
